Propranolol Stat Dose for AF with RVR
For atrial fibrillation with rapid ventricular response, administer propranolol 1 mg IV over 1 minute, and repeat as needed every 2 minutes up to a maximum of 3 doses (total 3 mg). 123
Dosing Protocol
The standard acute dosing regimen is:
- Initial dose: 1 mg IV push over 1 minute
- Repeat dosing: May repeat 1 mg every 2 minutes as needed
- Maximum: Up to 3 total doses (3 mg total)
- Onset of action: Within 5 minutes 3
This dosing is consistent across both the 2024 ACC/AHA/ACCP/HRS guidelines 1 and 2016 ESC guidelines 2, as well as FDA labeling 3.
Critical Considerations Before Administration
Propranolol is NOT First-Line for AF with RVR
While propranolol is effective, it is explicitly noted as NOT recommended as specific rate control therapy in AF by the ESC guidelines 2. The preferred beta-blockers are:
- Metoprolol (2.5-5 mg IV bolus over 2 minutes, up to 3 doses) 1
- Esmolol (500 μg/kg bolus, then 50-300 μg/kg/min infusion) 1
Propranolol is non-selective (blocks both β1 and β2 receptors), which increases risk of bronchospasm and other adverse effects compared to cardioselective agents.
Absolute Contraindications
Do NOT use propranolol if:
- Wolff-Parkinson-White syndrome with AF - Propranolol can paradoxically increase ventricular rate to dangerous levels (up to 267 bpm documented) when most QRS complexes are preexcited 4
- Heart failure with reduced ejection fraction (HFrEF) with hemodynamic instability - Use amiodarone instead 12
- Severe bronchospasm or active COPD exacerbation - Non-selective β-blockade
- Concurrent calcium channel blocker use - Risk of severe bradycardia, heart block, cardiovascular collapse 3
Special Clinical Scenarios Where Propranolol May Be Preferred
Thyrotoxicosis-Induced AF
Propranolol has unique advantages in hyperthyroid patients because it:
- Blocks peripheral conversion of T4 to active T3
- Provides additional benefit beyond heart rate control 5
- May be superior to metoprolol in this specific population 5
In thyrotoxic AF, propranolol addresses both the adrenergic excess and the direct thyroid hormone effects on cardiac myocytes.
Monitoring Requirements
- Continuous cardiac monitoring during administration
- Blood pressure monitoring - Risk of hypotension, especially with concurrent vasodilators 3
- Watch for bradycardia - Half-life is 2.4 hours IV 1
Dose Adjustments
- Elderly patients: Start at low end of dosing range; decreased clearance and longer half-life 33
- Hepatic impairment: Consider dose reduction; propranolol is extensively hepatically metabolized 33
- Renal impairment: No specific adjustment needed (not renally eliminated) 1
Common Pitfalls
- Using propranolol as first-line when metoprolol or diltiazem would be more appropriate
- Failing to identify WPW syndrome before administration - Can be life-threatening 4
- Combining with calcium channel blockers - Significant risk of cardiovascular collapse 3
- Using in decompensated heart failure - Negative inotropic effects can worsen outcomes
Why Other Agents Are Generally Preferred
Recent evidence suggests metoprolol has 26% lower risk of adverse events compared to diltiazem (10% vs 19% incidence) 6, and both are preferred over propranolol for routine AF with RVR due to better selectivity and safety profiles.